Home » Topics » BioWorld Science

BioWorld Science
RSS

New nitric oxide production inhibitors presented by FronThera US Pharmaceuticals

April 21, 2020

Cardurion Pharmaceuticals synthesizes new CAMK2 inhibitors

April 21, 2020

Genzyme identifies new GALC inhibitors

April 21, 2020

Regenacy Pharmaceuticals discloses HDAC1 and/or HDAC2 inhibitors

April 21, 2020

Arbidol shows superior efficacy compared to lopinavir/ritonavir in treating COVID-19

April 21, 2020

RAPT Therapeutics patents USP7 inhibitors

April 21, 2020

BCH-070, a novel antiparasitic candidate against multidrug-resistant malaria

April 21, 2020

First COVID-19 patient treated under emergency use IND with Stemedica's itMSCs

April 21, 2020

Promising topline data for Xeris' novel intramuscular injection formulation of diazepam

April 21, 2020

Alexion to initiate global phase III study of Ultomiris in severe COVID-19

April 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...